Calcium Atorvastatin

Takaitaccen Bayani:

Sunan API Nuni Ƙayyadaddun bayanai Farashin DMF EU DMF CEP
Calcium Atorvastatin Hypercholesterolemia Cikin Gida/CEP 29057 CEP 2015-034


Cikakken Bayani

Tags samfurin

BAYANIN KYAUTA

Fage

Calcium Atorvastatin shine mai hana HMG-CoA reductase tare da ƙimar IC50 na 150 nM.
HMG-CoA reductase shine babban enzyme na hanyar mevalonate wanda ke samar da cholesterol. HMG-CoA shine enzyme mai iyakancewa kuma yana da mahimmanci don rage matakan cholesterol na jini. HMG-CoA reductase yana cikin endoplasmic reticulum kuma ya ƙunshi yankuna takwas na transmembrane. Masu hana HMG-CoA reductase na iya haifar da LDL (low density lipoprotein) masu karɓa a cikin hanta. Yana haifar da haɓaka matakan catabolism na plasma LDL da rage yawan ƙwayar cholesterol na plasma wanda shine muhimmin mahimmancin kayyade atherosclerosis. HMG-CoA reductase yana taka muhimmiyar rawa a cikin haɗin cholesterol. HMG-CoA shine manufa ɗaya don rage ƙwayar cholesterol. HMG-CoA reductase shima muhimmin enzyme ne don haɓakawa. Ayyukan HMG-CoA reductase yana da alaƙa da lahani na ƙaura na ƙwayoyin cuta. Hana ayyukansa na iya haifar da zubar jini na intracerebral[1].
Atorvastatin shine mai hana HMG-CoA reductase tare da ƙimar IC50 na 154 nM. Yana da tasiri wajen magance wasu dyslipidemias da hypercholesterolemia[1]. Maganin Atorvastatin a 40 MG yana rage jimlar cholesterol na 40% bayan kwanaki 40. Hakanan ana amfani da ita don kula da masu ciwon bugun jini ko bugun jini tare da matakan cholesterol na al'ada.[2] Atorvastatin kuma yana rage ƙarancin ƙarancin lipoprotein apheresis a cikin marasa lafiya ta hanyar haifar da bayyanar masu karɓar LDL.
An daidaita shi zuwa metabolites da yawa waɗanda ke da mahimmanci don tasirin ayyukan warkewa ta hanyar CYP3A4 (cytochrome P450 3A4).[3]
Magana:
[1]. van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ: Tsawon inganci da amincin atorvastatin a cikin jiyya na nau'in nau'in III mai tsanani da hadewar dyslipidemia. Zuciya 2002, 88 (3): 234-238.
[2]. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT et al -matsakaicin adadin cholesterol, a cikin Gwajin Sakamakon Ciwon zuciya na Anglo-Scandinavian-- Rage Hannun Lipid (ASCOT-LLA): gwajin sarrafa bazuwar cibiyoyi da yawa. Lancet 2003, 361 (9364): 1149-1158.
[3]. Lennernas H: Magungunan magunguna na atorvastatin. Clin Pharmacokinet 2003, 42 (13): 1141-1160.

Tsarin sinadaran

Calcium - Atorvastatin

CERTIFICATION

2018 GMP-2
原料药GMP证书201811 (captopril, thalidomide da dai sauransu)
GMP-na-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

INGANTACCEN KYAUTA

Gudanar da inganci1

Shawara18Ayyukan Ƙididdigar Ingancin Ingancin waɗanda suka amince4, kuma6ayyukan suna ƙarƙashin amincewa.

Gudanar da inganci2

Babban tsarin kula da ingancin ingancin ƙasa da ƙasa ya kafa tushe mai ƙarfi don siyarwa.

Gudanar da inganci3

Ingantattun kulawa yana gudana cikin duk tsawon rayuwar samfurin don tabbatar da inganci da tasirin warkewa.

Gudanar da inganci4

Mawakan da ake gudanarwa na kwararru yana tallafawa ingancin bukatun yayin aikace-aikacen da rajista.

SAMUN SARAUTA

cpf5
cpf6

Layin Packaging Bottled na Koriya Countec

cpf7
cpf8

Layin Marufi na CVC Taiwan

cpf9
cpf10

Layin Packaging Board CAM na Italiya

cpf11

Jamus Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cf14-1

Dakin Kulawa na DCS

ABUNCI

Hadin gwiwar kasa da kasa
Hadin gwiwar kasa da kasa
Hadin kai na cikin gida
Hadin kai na cikin gida

  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana

    Rukunin samfuran